ISEC Healthcare Ltd. (SGX:40T)

ISEC Healthcare Income Statement

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	74.2	69.99	62.95	40.47	36.33
Revenue Growth (YoY)	6.00%	11.18%	55.56%	11.40%	-15.27%
Cost of Revenue	41.53	38.96	34.19	22.59	20.27
Gross Profit	32.67	31.04	28.77	17.88	16.06
Selling, General & Admin	14.12	12.26	10.43	8.62	8.39
Other Operating Expenses	-	1.28	1.45	0.57	0.56
Operating Expenses	14.12	13.54	11.88	9.18	8.95
Operating Income	18.55	17.49	16.88	8.69	7.11
Interest Expense	-0.57	-0.65	-0.56	-0.4	-0.42
Interest & Investment Income	-	-	-	0.22	0.31
Earnings From Equity Investments	-	-	-0	-0.01	-0.02
Currency Exchange Gain (Loss)	-	-	-	-0.13	0.03
Other Non Operating Income (Expenses)	0.73	0.46	0.44	0.33	0.31
EBT Excluding Unusual Items	18.71	17.3	16.77	8.7	7.32
Merger & Restructuring Charges	-	-	-	-0.05	-
Impairment of Goodwill	-1.52	-	-	-	-1.48
Gain (Loss) on Sale of Assets	-	-	-	-	0.02
Asset Writedown	-	-	-	-0	-
Other Unusual Items	-	0.01	0.01	0.44	0.66
Pretax Income	17.19	17.31	16.78	9.09	6.51
Income Tax Expense	4.29	4.16	4.05	2.21	2.06
Earnings From Continuing Operations	12.89	13.15	12.73	6.88	4.45
Minority Interest in Earnings	-0.07	-0.19	-0.21	0.03	0.24
Net Income	12.82	12.96	12.52	6.91	4.69
Net Income to Common	12.82	12.96	12.52	6.91	4.69
Net Income Growth	-1.07%	3.54%	81.32%	47.23%	-37.17%
Shares Outstanding (Basic)	575	573	564	550	548
Shares Outstanding (Diluted)	576	573	564	550	548
Shares Change (YoY)	0.38%	1.73%	2.42%	0.52%	3.79%
EPS (Basic)	0.02	0.02	0.02	0.01	0.01
EPS (Diluted)	0.02	0.02	0.02	0.01	0.01
EPS Growth	-1.33%	1.80%	77.60%	45.93%	-39.25%
Free Cash Flow	5.86	13.75	12.14	11.57	5.56
Free Cash Flow Per Share	0.01	0.02	0.02	0.02	0.01
Dividend Per Share	0.010	0.016	0.016	0.011	0.008
Dividend Growth	-37.89%	3.21%	48.57%	31.25%	-
Gross Margin	44.03%	44.34%	45.70%	44.18%	44.20%
Operating Margin	25.00%	24.99%	26.82%	21.48%	19.56%
Profit Margin	17.28%	18.52%	19.89%	17.06%	12.91%
Free Cash Flow Margin	7.90%	19.65%	19.28%	28.58%	15.30%
EBITDA	20.72	19.49	18.58	10.31	8.79
EBITDA Margin	27.93%	27.84%	29.52%	25.48%	24.18%
D&A For EBITDA	2.17	2	1.7	1.62	1.68
EBIT	18.55	17.49	16.88	8.69	7.11
EBIT Margin	25.00%	24.99%	26.82%	21.48%	19.56%
Effective Tax Rate	24.98%	24.05%	24.14%	24.29%	31.59%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.